BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 13022866)

  • 1. The mechanism responsible for the hypercholesteremia induced by triton WR-1339.
    FRIEDMAN M; BYERS SO
    J Exp Med; 1953 Jan; 97(1):117-30. PubMed ID: 13022866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathogenesis of hyperlipemia induced by means of surface-active agents. II. Failure of exchange of cholesterol between the plasma and the liver in rabbits given triton WR 1339.
    HIRSCH RL; KELLNER A
    J Exp Med; 1956 Jul; 104(1):15-24. PubMed ID: 13332177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceleration of hepatic cholesterol synthesis by triton WR-1339.
    FRANTZ ID; HINKELMAN BT
    J Exp Med; 1955 Mar; 101(3):225-32. PubMed ID: 13233448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diphenylilethylacetic acid inhibits hypercholesteremia induced by triton.
    GARATTINI S; MORPURGO C; PASSERINI N
    Experientia; 1956 Sep; 12(9):347-8. PubMed ID: 13365594
    [No Abstract]   [Full Text] [Related]  

  • 5. Observations concerning the production and excretion of cholesterol in mammals. IX. The mechanism of the hypercholesteremic effect of cholic acid.
    BYERS SO; FRIEDMAN M; BIGGS MW; GUNNING B
    J Exp Med; 1953 Apr; 97(4):511-24. PubMed ID: 13052817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triton hypercholesteremia: cause or consequence of augmented cholesterol synthesis.
    BYERS SO; FIEDMAN M; SUGIYAMA T
    Am J Physiol; 1963 Jun; 204():1100-2. PubMed ID: 14017481
    [No Abstract]   [Full Text] [Related]  

  • 7. The composition of the lipoproteins in the plasma of rabbits with hypercholesterolaemia or triton WR-1339-induced hyperlipaemia.
    GARLICK DG; COURTICE FC
    Q J Exp Physiol Cogn Med Sci; 1962 Jul; 47():211-20. PubMed ID: 13896985
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanism underlying hypercholesteremia induced by triton WR-1339.
    FRIEDMAN M; BYERS SO
    Am J Physiol; 1957 Sep; 190(3):439-45. PubMed ID: 13470068
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of intravenous Triton WR-1339 on factor VII coagulant activity and plasma lipoproteins in normocholesterolaemic and hypercholesterolaemic rabbits.
    Mitropoulos KA; Miller GJ; Howarth DJ; Reeves BE; Cooper JA
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):583-91. PubMed ID: 7841315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathogenesis of hyperlipemia induced by means of surface-active agents. I. Increased total body cholesterol in mice given triton WR 1339 parenterally.
    HIRSCH RL; KELLNER A
    J Exp Med; 1956 Jul; 104(1):1-13. PubMed ID: 13332176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of intestinal lipoprotein clearance in rabbits injected with Triton WR 1339-ethyl oleate.
    Nagata Y; Zilversmit DB
    J Lipid Res; 1987 Jun; 28(6):684-92. PubMed ID: 3611971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triton hyperlipemia in dogs. II. Atheroscieross, diffuse lipidosis, and deletion of fat stores produced by prolonged administration of the non-tonic surface-active agent.
    SCANU A; ORIENTE P; SZAJEWSKI JM; McCORMACK LJ; PAGE IH
    J Exp Med; 1961 Sep; 114(3):279-94. PubMed ID: 13747053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of a non-ionic detergent (Triton WR 1339) on the removal of triglyceride fatty acids from the blood of the rat.
    Otway S; Robinson DS
    J Physiol; 1967 May; 190(2):309-19. PubMed ID: 6049000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a nonionic detergent (Triton WR 1339) in healthy cats to assess hepatic secretion of triglyceride.
    Hall JA; Gradin JL; Andreasen CB; Wander RC
    Am J Vet Res; 2000 Aug; 61(8):941-50. PubMed ID: 10951988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of a non-ionic detergent (Triton WR 1339) to determine rates of triglyceride entry into the circulation of the rat under different physiological conditions.
    Otway S; Robinson DS
    J Physiol; 1967 May; 190(2):321-32. PubMed ID: 6049002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the mechanism of enhancement of carbon tetrachloride hepatotoxicity by Triton WR 1339.
    de Ferreyra EC; de Toranzo EG; de Fenos OM; Castro JA
    Br J Exp Pathol; 1981 Oct; 62(5):512-8. PubMed ID: 7295545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of ethinyl estradiol-induced bile secretory failure with Triton WR-1339.
    Simon FR; Gonzalez M; Sutherland E; Accatino L; Davis RA
    J Clin Invest; 1980 Apr; 65(4):851-60. PubMed ID: 6244335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol lowering effect of SG-GN3, the extract of salted and fermented small shrimps, Acetes japonicus, in Triton WR-1339 or high cholesterol-diet induced hypercholesterolemic rats.
    Seok SH; Park JH; Cho SA; Choi SA; Park JH
    J Ethnopharmacol; 2004 Apr; 91(2-3):231-5. PubMed ID: 15120444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal by triton WR-1339 of ethynyloestradiol-induced hepatic cholesterol esterification.
    Davis RA; Showalter R; Kern F
    Biochem J; 1978 Jul; 174(1):45-51. PubMed ID: 697762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [EXPERIMENTAL OBSERVATIONS ON THE TRITON TEST IN THE RAT].
    GINOULHIAC E
    Farmaco Prat; 1964 Apr; 19():200-9. PubMed ID: 14145632
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.